comparemela.com

Goodrx Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innealta Capital LLC Takes $91,000 Position in GoodRx Holdings, Inc (NASDAQ:GDRX)

Innealta Capital LLC purchased a new position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 13,555 shares of the company’s stock, valued at approximately $91,000. A number of other institutional investors […]

Olympiad Research LP Raises Holdings in GoodRx Holdings, Inc (NASDAQ:GDRX)

Olympiad Research LP increased its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 20.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 60,397 shares of the company’s stock after acquiring an additional 10,213 shares during the quarter. Olympiad […]

GoodRx (NASDAQ:GDRX) Lifted to Outperform at Royal Bank of Canada

Royal Bank of Canada upgraded shares of GoodRx (NASDAQ:GDRX – Free Report) from a sector perform rating to an outperform rating in a research note published on Thursday, MarketBeat Ratings reports. The firm currently has $10.00 price target on the stock, up from their previous price target of $8.00. GDRX has been the subject of […]

GoodRx (NASDAQ:GDRX) Upgraded by Royal Bank of Canada to Outperform

Royal Bank of Canada upgraded shares of GoodRx (NASDAQ:GDRX – Free Report) from a sector perform rating to an outperform rating in a research note published on Thursday morning, Marketbeat reports. Royal Bank of Canada currently has $10.00 price objective on the stock, up from their previous price objective of $8.00. Other equities research analysts […]

GoodRx (NASDAQ:GDRX) Upgraded at Royal Bank of Canada

Royal Bank of Canada upgraded shares of GoodRx (NASDAQ:GDRX – Free Report) from a sector perform rating to an outperform rating in a report issued on Thursday morning, MarketBeat reports. They currently have $10.00 price target on the stock, up from their prior price target of $8.00. A number of other equities research analysts have […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.